Jim Frates

Jim Frates

Director of Finance/CFO chez AMYLYX PHARMACEUTICALS, INC.

Fortune : 770 401 $ au 31/03/2024

56 ans
Consumer Services
Commercial Services
Health Technology

Profil

James M.
Frates
is currently the Director at St. Francis House, Independent Director at SAGE Therapeutics, Inc., and Chief Financial Officer at Amylyx Pharmaceuticals, Inc. He previously worked as the Director at GPC Biotech AG and National Director at The Association of Bioscience Financial Officers.
He was also the Vice President-Investment Banking at Robertson Stephens & Co. and the Chief Financial Officer & Senior Vice President at Alkermes Plc.
Frates has served as Treasurer & Trustee at St. Paul's School and Roxbury Latin School.
Frates holds an MBA degree from Harvard Business School and an undergraduate degree from Harvard College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/04/2024 252 495 ( 0,37% ) 717 086 $ 31/03/2024
03/01/2024 2 845 ( 0,00% ) 53 315 $ 31/03/2024

Postes actifs de Jim Frates

SociétésPosteDébut
SAGE THERAPEUTICS, INC. Director/Board Member 10/06/2014
AMYLYX PHARMACEUTICALS, INC. Director of Finance/CFO 01/01/2021
Director/Board Member -
Tous les postes actifs de Jim Frates

Anciens postes connus de Jim Frates

SociétésPosteFin
ALKERMES PLC Director of Finance/CFO 11/01/2021
Director/Board Member 01/06/2009
Director/Board Member 01/01/2009
Robertson Stephens & Co. Corporate Officer/Principal 01/06/1998
Roxbury Latin School Director/Board Member -
Voir l'expérience en détail de Jim Frates

Formation de Jim Frates

Harvard Business School Masters Business Admin
Harvard College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jim Frates

Relations

98

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
SAGE THERAPEUTICS, INC.

Health Technology

AMYLYX PHARMACEUTICALS, INC.

Health Technology

ALKERMES PLC

Health Technology

Entreprise privées4

Commercial Services

Robertson Stephens & Co.

Finance

Commercial Services

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jim Frates